Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ETS2 Antikörper (Center)

ETS2 Reaktivität: Human, Ratte WB, IF, IHC (p), IP, ChIP, ICC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN2855845
  • Target Alle ETS2 Antikörper anzeigen
    ETS2 (V-Ets Erythroblastosis Virus E26 Oncogene Homolog 2 (ETS2))
    Bindungsspezifität
    • 9
    • 7
    • 7
    • 6
    • 6
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Center
    Reaktivität
    • 46
    • 10
    • 8
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Human, Ratte
    Wirt
    • 41
    • 6
    Kaninchen
    Klonalität
    • 44
    • 3
    Polyklonal
    Konjugat
    • 27
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser ETS2 Antikörper ist unkonjugiert
    Applikation
    • 35
    • 22
    • 16
    • 15
    • 5
    • 5
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Chromatin Immunoprecipitation (ChIP), Immunocytochemistry (ICC)
    Produktmerkmale
    Rabbit Polyclonal antibody to ETS2 (v-ets erythroblastosis virus E26 oncogene homolog 2 (avian))
    ETS2 antibody
    Aufreinigung
    Purified by antigen-affinity chromatography.
    Immunogen
    Recombinant protein encompassing a sequence within the center region of human ETS2. The exact sequence is proprietary.
    Isotyp
    IgG
  • Applikationshinweise
    Suggested dilution Reference ChIP assay Assay-dependent dilution ICC/IF 1:100-1:1000* IHC (Formalin-fixed paraffin-embedded sections) 1:100-1:1000* Immunoprecipitation 1:100-1:500* Western blot 1:500-1:3000* Not tested in other applications. *Optimal dilutions/concentrations should be determined by the researcher.Suggested dilutionReferenceChIP assayAssay-dependent dilution ICC/IF1:100-1:1000* IHC (Formalin-fixed paraffin-embedded sections)1:100-1:1000* Immunoprecipitation1:100-1:500* Western blot1:500-1:3000*
    Kommentare

    Positive Control: HeLa

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 mg/mL
    Buffer
    1XPBS, 1 % BSA, 20 % Glycerol ( pH 7). 0.01 % Thimerosal was added as a preservative.
    Konservierungsmittel
    Thimerosal (Merthiolate)
    Vorsichtsmaßnahmen
    This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Keep as concentrated solution. Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
  • Gluck, Glathar, Tsompana, Nowak, Garrett-Sinha, Buck, Sinha: "Molecular dissection of the oncogenic role of ETS1 in the mesenchymal subtypes of head and neck squamous cell carcinoma." in: PLoS genetics, Vol. 15, Issue 7, pp. e1008250, (2019) (PubMed).

    Yuan, Jiang, Mayakonda, Huang, Ding, Lin, Yu, Lu, Loh, Chow, Savage, Tyner, Lin, Koeffler: "Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma." in: Cancer research, Vol. 77, Issue 23, pp. 6614-6626, (2018) (PubMed).

    Helbig, Wockner, Bouendeu, Hille-Betz, McCue, French, Edwards, Pickett, Reddel, Chenevix-Trench, Dörk, Beesley: "Functional dissection of breast cancer risk-associated TERT promoter variants." in: Oncotarget, Vol. 8, Issue 40, pp. 67203-67217, (2017) (PubMed).

  • Target
    ETS2 (V-Ets Erythroblastosis Virus E26 Oncogene Homolog 2 (ETS2))
    Andere Bezeichnung
    ETS2 (ETS2 Produkte)
    Synonyme
    0123/09 antikoerper, 0608/07 antikoerper, 0998/12 antikoerper, 3520 antikoerper, CG17077 antikoerper, CG8705 antikoerper, D-Ets-2 antikoerper, D-ets-2 antikoerper, DMPOINT1A antikoerper, Dmel\\CG17077 antikoerper, E(E2F)3D antikoerper, EK3-2 antikoerper, ETS2 antikoerper, EY3-1 antikoerper, Ets antikoerper, Ets2 antikoerper, Ets58AB antikoerper, Ets94F antikoerper, PNT-P1 antikoerper, PNTP1 antikoerper, PNTP2 antikoerper, POINT antikoerper, Pnt antikoerper, Pnt-P1 antikoerper, PntP1 antikoerper, PntP2 antikoerper, Pointed-P1 antikoerper, ets94F antikoerper, l(3)07825 antikoerper, l(3)j1B7 antikoerper, l(3)s118306 antikoerper, png antikoerper, pnt-P1 antikoerper, pnt-P2 antikoerper, pntP2 antikoerper, pntegfr antikoerper, pointed-RC antikoerper, ptd antikoerper, zgc:92106 antikoerper, wu:fe02h08 antikoerper, wu:fk74c05 antikoerper, AU022856 antikoerper, Ets-2 antikoerper, ETS2IT1 antikoerper, c-ets-2 antikoerper, pointed antikoerper, v-ets avian erythroblastosis virus E26 oncogene homolog 2 antikoerper, E26 avian leukemia oncogene 2, 3' domain antikoerper, ETS proto-oncogene 2, transcription factor antikoerper, pnt antikoerper, ets2 antikoerper, Ets2 antikoerper, ETS2 antikoerper
    Hintergrund
    ETS transcriptions factors, such as ETS2, regulate numerous genes and are involved in stem cell development, cell senescence and death, and tumorigenesis. The conserved ETS domain within these proteins is a winged helix-turn-helix DNA-binding domain that recognizes the core consensus DNA sequence GGAA/T of target genes (Dwyer et al., 2007 [PubMed 17986575]).[supplied by OMIM]

    Cellular Localization: Nucleus
    Molekulargewicht
    53 kDa
    Gen-ID
    2114
    Pathways
    EGFR Signaling Pathway, Myometrial Relaxation and Contraction
Sie sind hier:
Kundenservice